The UK based genomic medicine company Congenica invited us to share our story on their blog. Have a read here. We are thrilled that Congenica's Patient Advocacy and Engagement Lead, Charlie Steward, PhD, has agreed to be on the Scientific Advisory Board of FAM177A1 Research Fund. He is a tremendous asset to our team, both as an experienced genetic scientist and as a fellow parent to two children with a rare disease.
Commentaires